Strategic Partnership Lucigen was acquired by LGB Biosearch Technologies, signaling a strong channel for cross-sell of nucleic acid purification, extraction, and transposon mutagenesis solutions across expanded product lines and regional footprints.

Catalog and OEM As an ISO 13485-certified manufacturer offering catalog and custom solutions, there is a clear opportunity to pitch OEM partnerships and tailored assay components to fit customer workflows in molecular diagnostics and synthetic biology.

Global Expansion Recent and past collaborations with Gx partners and distribution deals indicate potential for scale selling into Asia Pacific, Europe, Middle East, Canada, and Latin America via existing networks.

Next-Gen Focus Lucigen’s core strengths in enzyme evolution and applications like next-gen sequencing and synthetic biology present upsell prospects for high-throughput kits, reagents, and custom enzymes aligned with emerging diagnostic and research needs.

Analytics Ready With a technology stack including Tableau, Power BI, SAP BI, and Snowflake, there is value in offering data-driven catalog optimization, performance analytics, and integrated lab informatics solutions to improve adoption and customer success.